Company Encyclopedia
View More
name
Canopy Growth
CGC.US
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands.
4.514 T
CGC.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
PharmaceuticalsIndustry
Industry Ranking138/183
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-62.06%E
    • Profit Margin-138.49%E
    • Gross Margin32.85%C
  • Growth ScoreC
    • Revenue YoY-4.81%D
    • Net Profit YoY34.50%B
    • Total Assets YoY-15.71%E
    • Net Assets YoY40.22%A
  • Cash ScoreD
    • Cash Flow Margin-72.21%D
    • OCF YoY-4.81%D
  • Operating ScoreD
    • Turnover0.24D
  • Debt ScoreB
    • Gearing Ratio31.20%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Canopy Growth launches Claybourne Gassers vapes in Canada, featuring liquid diamonds to expand in high-growth vape segment.

    In Smiths Falls, Ontario, Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) has unveiled the nationwide release of Claybourne Gassers, a fresh range of All-in-One (AIO) vapes with liquid diamonds. This launch signifies Claybourne's initiation into Canada's vape sector, expanding its dominance in potent infused products. The Claybourne Gassers launch is a move by Canopy Growth to diversify its offerings and tap into the growing vape market.

    Unusual Whales·
    US
    CGC
    +4.31%
    Unusual Whales·
    US
    CGC
    +4.31%

    Canopy Growth Launches Claybourne Gassers Liquid Diamond Vapes Across Canada

    Canopy Growth Corporation has launched Claybourne Gassers, a new line of All-in-One vapes with liquid diamonds, in Canada. The collection includes three high-THC vapes and features advanced technology. This launch marks Claybourne's entry into Canada's vape market and strengthens Canopy Growth's presence in the high-growth vape segment. Additionally, Claybourne is introducing Frosted Flyers pre-rolls in select regions. The news was generated by Public Technologies using AI and is based on content published by Canopy Growth Corp. via Business Wire.

    Reuters·
    US
    CGC
    +4.31%
    Reuters·
    US
    CGC
    +4.31%

    TLRY, CGC, CRON: Cannabis Stocks Jump as U.S. Medicare Considers Coverage

    Cannabis stocks, including Tilray, Canopy Growth, and Cronos Group, surged as U.S. Medicare considers covering CBD treatments for certain patients, potentially boosting the struggling industry. The initiative may focus on seniors receiving cancer or palliative care. This follows a previous rally in September when President Trump supported Medicare coverage for cannabis treatments. Tilray's stock has a Moderate Buy rating, with a price target suggesting significant upside.

    Tip Ranks·
    US
    CGC
    +4.31%
    US
    CRON
    -0.80%
    US
    TLRY
    +2.27%
    Tip Ranks·
    US
    CGC
    +4.31%
    US
    CRON
    -0.80%
    US
    TLRY
    +2.27%

    Canopy Growth Launches New Spectrum Therapeutics Softgels in Australia

    Canopy Growth Corporation has expanded its Spectrum Therapeutics portfolio in Australia by launching new softgel capsules for medical cannabis patients. The new products include Spectrum Yellow, Red, and Blue Cannabis Oil Softgels, offering various CBD and THC combinations. This expansion aims to provide more choices for patients and prescribers, reinforcing Canopy Growth's commitment to its international medical cannabis business. The softgels are available through authorized prescribers in Australia.

    Reuters·
    US
    CGC
    +4.31%
    Reuters·
    US
    CGC
    +4.31%

    Canopy Growth Just Topped Earnings Estimates. Should You Buy, Sell, or Hold CGC Stock for November 2025?

    Canopy Growth Just Topped Earnings Estimates. Should You Buy, Sell, or Hold CGC Stock for November 2025?

    Barchart Option·
    US
    CGC
    +4.31%
    Barchart Option·
    US
    CGC
    +4.31%
    © 2025 Longbridge｜Disclaimer